Insulin-like growth factor I is essential for postnatal growth in response to growth hormone

Endocrinology

Volumn 140, Issue 11, 1999, Pages 5178-5184

  Liu, Jun Li ^a   LeRoith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ADOLESCENT; ANIMAL MODEL; ARTICLE; BODY GROWTH; CONTROLLED STUDY; DELETION MUTANT; GENE EXPRESSION; HORMONE RESPONSE; LIVER; MOUSE; MOUSE MUTANT; NONHUMAN; ORGAN WEIGHT; POSTNATAL GROWTH; PRIORITY JOURNAL;

EID: 0033303497     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.11.7151     Document Type: Article

References (49)

1. Mode of action of pituitary growth hormone on target cells
2. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
3. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4
4. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
5. Role of insulin-like growth factors in embryonic and postnatal growth
6. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
7. IGF-I is required for normal embryonic growth in mice
8. Molecular mechanism of growth hormone action
9. From sulphation factor to IGF-I, 40 years of research on the regulation of cartilage growth
10. Somatomedin: Proposed designation for sulphation factor
11. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth
12. Growth hormone stimulates longitudinal bone growth directly
13. Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin
14. Growth hormone and insulin-like growth factor I induce bone morphogenetic proteins 2 and 4: A mediator role in bone and tooth formation?
15. Effects of growth hormone and insulin-like growth factor-I on colony formation of rabbit epiphyseal chondrocytes at different stages of maturation
16. The stimulatory effect of growth hormone, prolactin, and placental lactogen on β-cell proliferation is not mediated by insulin-like growth factor-I
17. Normal growth and development in the absence of hepatic insulin-like growth factor I
18. Insulin-like growth factor-I affects perinatal lethality and postnatal development in a gene dosage-dependent manner: Manipulation using the Cre/loxP system in transgenic mice
19. Developmental regulation of the rat insulin-like growth factor I receptor gene
20. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency
21. Growth hormone induces expression of c-jun and jun B oncogenes and employs a protein kinase C signal transduction pathway for the induction of c-fos oncogene expression
22. Rapid nuclear actions of growth hormone
23. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse
24. The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells
25. Fetal growth and placental function
26. Plasma clearance of radiolabelled IGF-1 in the late gestation ovine fetus
27. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
28. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development
29. Phenotypic alterations in insulin-deficient mutant mice
30. Insulin-like growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells
31. Insulin-like growth factors: A role in growth hormone negative feedback and body weight regulation via brain
32. Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary
33. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans
34. A dual effector theory of growth-hormone action
35. Insulin-like growth factor gene targeting
36. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
37. Effects of Igf1 gene deletion on postnatal growth patterns
38. Growth hormone (GH) insensitivity due to primary GH receptor deficiency
39. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
40. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons
41. Effect of excessive secretion of growth hormone on tissues of the rat, with particular reference to the heart and skeletal muscle
42. Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice
43. Hepatomegaly induced by the pulsatile, but not continuous, intravenous administration of purified chicken growth hormone in broiler pullets: Liver composition and nucleic-acid content
44. Accelerated growth and visceral lesions in transgenic mice expressing foreign genes of the growth hormone family: An overview
45. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization
46. Inactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasia
47. First identification of a gene defect for hypophosphatasia: Evidence that alkaline phosphatase acts in skeletal mineralization
48. Effect of locally infused IGF-I on femoral gene expression and bone turnover activity in old rats
49. The action of GH/IGF-I/IGFBP in osteoblasts and osteoclasts